426 results on '"Torimura T."'
Search Results
2. Immunological inflammatory biomarkers as prognostic predictors for advanced hepatocellular carcinoma
3. Structure and Ultrastructure of the Normal and Diseased Liver
4. List of Contributors
5. Evaluating the effect of intrahepatic lesion status on the prognosis of advanced hepatocellular carcinoma patients with extrahepatic metastasis: A prospective multicenter cohort study
6. β1-Integrin mediates cell adhesion, haptotaxis, and chemokinesis of hepatoma cells
7. Intra-arterial therapy with cisplatin suspension in lipiodol and 5-fluorouracil for hepatocellular carcinoma with portal vein tumour thrombosis
8. Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen
9. MECHANISM OF HEPATOMA CELL INVASION INDUCED BY AUTOCRINE MOTILITY FACTOR (AMF)
10. RELATIONSHIP BETWEEN TRANSFORMING GROWTH FACTOR-β 1 AND CELL GROWTH AND APOPTOSIS IN HEPATOMA CELLS
11. Gastrointestinal: Abdominal pain, diarrhea, and bloody stools in a patient treated for renal cell carcinoma with sunitinib
12. Formation of black pigment gallstone in a hamster model of experimental cirrhosis
13. Chapter 2 - Structure and Ultrastructure of the Normal and Diseased Liver
14. Health-Related Quality of Life in patients with autoimmune hepatitis
15. THU-233 - Health-Related Quality of Life in patients with autoimmune hepatitis
16. P459 RESCUE THERAPY BY AUTOLOGOUS INFUSION OF GRANULOCYTE-COLONY STIMULATING FACTOR-MOBILIZED PERIPHERAL BLOOD CD34-POSITIVE CELLS IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS
17. 1304 PEPTIDES PRODUCED BY AUTOLYSIS REACTIONS FROM WHEAT BRAN HAVE THERAPEUTIC EFFECTS IN NONALCOHOLIC STEATOHEPATITIS
18. 311 EX VIVO-EXPANDED PERIPHERAL CD34+ CELLS FOR CHRONICALLY INJURED LIVER TREATMENT: IN VITRO AND IN VIVO STUDIES
19. 1053 A NOVEL SYNTHETIC SULFOGLYCOLIPID SULFOQUINOVOSYLACYL PROPANEDIOL (SQAP) SWITCHES OFF TUMOR ANGIOGENIC POTENTIAL OF HEPATOCELLULAR CARCINOMA THROUGH THE UPREGULATION OF VON HIPPEL–LINDAU PROTEIN
20. 1023 COMPARISON OF TIME TO PROGRESSION BETWEEN SINGLE TACE AND HEPATIC ARTERIAL INFUSION CHEMOTHERAPY PRIOR TO TACE FOR THE PATIENTS WITH MULTINODULAR HEPATOCELLULAR CARCINOMA
21. 803 ADIPONECTIN EXPRESSED IN LIVER DIRECTLY IMPROVES NONALCOHOLIC STEATOHEPATITIS (NASH) BY WAY OF ANTI-INFLAMMATION AND ANTI-OXIDATIVE STRESS
22. Validating a Markov Model of Treatment for Hepatitis C Virus-related Hepatocellular Carcinoma
23. 356 RECENT PROGRESS IN MANAGEMENT OF HEPATOCELLULAR CARCINOMA DIAGNOSED DURING SURVEILLANCE IN JAPAN
24. 713 Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease patients: Double-blind placebo-controlled study
25. 239 Surveillance program for early detection of hepatocellular carcinoma in japan. Result of specialized department of liver disease
26. Suppression of transforming growth factor-β effects up-regulates expression of regeneration factors in liver cirrhosis
27. Peroxisome proliferator-activator receptor-α activator (PPAR-α) dose not inhibit the activation of human hepatic stellate cells by IL-1β
28. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of β1 integrins
29. Relation of type II transforming growth factor-beta receptor to hepatic fibrosis and hepatocellular carcinoma.
30. Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats.
31. OK-432 treatment increases matrix metalloproteinase-9 production and improves dimethylnitrosamine-induced liver cirrhosis in rats.
32. Serum carboxy-terminal cross-linked telopeptide of type I collagen reflects bone metastasis in hepatocellular carcinoma.
33. OK-432 enhances the expression and activity of matrix metalloproteinase-9 in rat Kupffer cells and suppresses rat experimental hepatic fibrosis
34. Fungus thielavia minor blocks hepatic stellate cell proliferation and inhibits experemental hepatic fibrosis in rats
35. Relaxing effect of interleukin-1 on rat cultured Ito cells
36. The Significance of Colocalization of Plasminogen Activator Inhibitor-1 and Vitronectin in Hepatic Fibrosis
37. Evaluation of hyaluronic acid binding ability of hepatic sinusoidal endothelial cells in rats with liver cirrhosis
38. P-97 Laminin with type IV collagen enhances malignant phenotype of hepatoma cells
39. Portal hypertension with liver cirrhosis causes reduced contraction and histological changes in gallbladder
40. Transforming Growth Factorβ1, Extracellular Matrix, and Inflammatory Cells in Wound Repair Using a Closed Duodenal Loop Pancreatitis Model Rat: Immunohistochemical Study
41. Leukocyte Adhesion Molecules in the Liver and Plasma Cytokine Levels in Endotoxin-Induced Rat Liver Injury
42. Significance of Serum Type-IV Collagen Levels in Various Liver Diseases Measurement with a One-Step Sandwich Enzyme Immunoassay Using Monoclonal Antibodies with Specificity for Pepsin-Solubilized Type-IV Collagen
43. Radiographic Evidence of Cholecystokinin Octapeptide Receptors in the Hamster Gallbladder
44. Validating a Markov Model of Treatment for Hepatitis C Virus-related Hepatocellular Carcinoma.
45. Transforming Growth Factorβ1, Extracellular Matrix, and Inflammatory Cells in Wound Repair Using a Closed Duodenal Loop Pancreatitis Model Rat: Immunohistochemical Study.
46. Laminin deposition to type IV collagen enhances haptotaxis, chemokinesis, and adhesion of hepatoma cells through b1-integrins
47. Estrogen upregulates nitric oxide synthase expression in cultured rat hepatic sinusoidal endothelial cells
48. Gastrointestinal: Abdominal pain, diarrhea, and bloody stools in a patient treated for renal cell carcinoma with sunitinib.
49. Significance of serum tissue inhibitor of metalloproteinases-1 in various liver diseases
50. Involvement of arterial blood supply in the proliferation of hepatocellular carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.